March 2, 2013
During the 2013 session of the Maryland General Assembly, student advocates from the School of Pharmacy had an extraordinary opportunity to encourage legislators to support the rapidly expanding role of pharmacists in health care.
February 25, 2013
Local campaign is part of national effort to raise awareness about the need for patients with chronic conditions to take medications as directed.
February 19, 2013
John Grabenstein, RPh, PhD, visits the School of Pharmacy to speak about immunization advocacy and his career-long efforts to educate and train pharmacists to provide this valuable service.
February 14, 2013
Following a rigorous two-year review process, the Accreditation Council for Pharmacy Education (ACPE) reaccredits the Doctor of Pharmacy program at the University of Maryland School of Pharmacy.
February 6, 2013
School of Pharmacy professor is an innovative leader in community and ambulatory pharmacy.
February 5, 2013
“America’s Got Regulatory Science Talent” judges award student first prize for his guidelines to improve reporting of adverse medication events to the Food and Drug Administration.
January 31, 2013
The Mass Spectrometry facility at the University of Maryland School of Pharmacy will lead investigation to identify and characterize new biomarkers of radiation damage.
January 31, 2013
Longtime staff member Gwen Simmons retires from the University of Maryland School of Pharmacy after 38 years of service.
January 30, 2013
APhA-ASP’s Operation Heart launches campaign to highlight partnership with Million Hearts and educate public about the “ABCS” of heart disease and stroke prevention.
January 22, 2013
APhA-ASP launches program to provide guidance and support to undergraduates from the Pre-Pharmacy Society at the University of Maryland, College Park.
January 11, 2013
Sally Van Doren, PharmD, president and chief executive officer at BioSoteria, Inc., died on December 19, in Cuzco, Peru.
January 10, 2013
Heart failure and diabetes patients in the north paid more, adhered more to use of Part D drugs in first two years of the Medicare option, says School of Pharmacy professor.
